Ramky Infrastructure Limited has entered into a Share Purchase Agreement to sell its subsidiary, Visakha Pharmacity Limited (VPCL), for a consideration of ₹165.24 crore. The agreement was finalised on 30 March 2026, following the approval by the company’s Board of Directors on 28 March 2026.
VPCL, a subsidiary of Ramky Infrastructure, had 51% of its share capital held by the parent company. For the financial year 2024-25, VPCL reported a consolidated turnover of ₹4,093.29 million and a standalone turnover of ₹4,012.59 million. The Profit Before Tax (PBT) for the same period was ₹400.37 million on a consolidated basis and ₹420.86 million standalone, while the Profit After Tax (PAT) stood at ₹296.56 million and ₹317.32 million, respectively. The net worth of VPCL was reported at ₹3,023.26 million on a consolidated basis and ₹3,055.76 million standalone.
The shares of VPCL have been sold to Brij Gopal Construction Company Private Limited (BGCCPL). The transaction is not a related party transaction, and BGCCPL does not belong to the promoter group of Ramky Infrastructure. The completion of the sale is expected within 10 days from the execution of the Share Purchase Agreement.
The sale involves the transfer of 91,80,000 equity shares of VPCL, representing the 51% stake held by Ramky Infrastructure.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).